MedPath

Study of Epidemiologic Investigation and Mechanism of Brain Network of Otologic and Cognitive Function With Post-COVID-19

Completed
Conditions
Cognitive Decline
COVID-19
Otological Disease
Registration Number
NCT05787301
Lead Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Brief Summary

The purpose of this study was to analysis the incidence of ear symptoms, cognitive function decline and emotional disorders in Chinese people who were infected with COVID-19, exploring the impact of COVID-19 on the auditory system, cognitive function and emotional function, and analyzing the changes in functional connectivity of brain network after COVID-19 infection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Confirmed cases of COVID-19 that test positive for nucleic acid or antigen
  • After infection with COVID-19, the patient has experienced hearing loss, tinnitus, ear tightness, ear pain, vertigo and other ear symptoms, memory loss, depression and so on
Exclusion Criteria
  • Diagnosed cognitive disability
  • Patients with confirmed Meniere's disease, auditory neuropathy, and heavy noise exposure
  • Those with incomplete basic information or for other reasons are unable to complete questionnaires and other listening and cognitive assessments

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The correlation between the peak of COVID-19 transmission and the popularity of related online termsthrough study completion, an average of 3 months

The correlation between the peak of COVID-19 transmission and the popularity of related online terms

Mini-Mental State Examination score and gradethrough study completion, an average of 3 months

There are 30 points in the Mini-Mental State Examination (MMSE) scale. The score of 27-30 is normal, and 21-26 is mild dementia. 10-20 is moderate dementia; On a scale of 0 to 9, dementia is severe

Symptom incidencethrough study completion, an average of 3 months

According to the questionnaire survey of 748 patients, the incidence of hearing loss, tinnitus, ear tightness, earache, vertigo or other cognitive and emotional problems after COVID-19 was analyzed.

Pittsburgh Sleep Quality Interview score and gradethrough study completion, an average of 3 months

Pittsburgh Sleep Quality Index (PSQI) Scale total scores 21 points. A score of 0-5 indicates good sleep quality; A score of 6-10 indicates good sleep quality; 11-15 points, indicating average sleep quality; A score of 16 to 21 indicates poor sleep quality

Hamilton depression score and gradethrough study completion, an average of 3 months

For the 24th version of Hamilton depression Scale (HAMD), the total score \> 35 May indicate severe depression; 21-35, may be mild to moderate depression; 9-20, suspected depression; \< 8 indicates normal.

Pure tone averagethrough study completion, an average of 3 months

According to the WHO grading standard of hearing loss in 1980, the average pure tone threshold (PTA) of 0.5k, 1k, 2k and 4kHz in better ears was defined as normal hearing, 26-40 dB HL(hearing level) was defined as mild hearing loss, and 41-55 dB HL was defined as moderate hearing loss. 56-70 dB HL was moderate to severe hearing loss, 71-90 dB HL was severe hearing loss, and ≥91 dB HL was extremely severe hearing loss.

Montreal Cognitive Assessment score and gradethrough study completion, an average of 3 months

The total score of the Montreal Cognitive Assessment (MoCA) scale is 30 points, generally ≥26 points normal, 18-26 points mild cognitive impairment, 10-17 points moderate cognitive impairment, and \< 10 points severe cognitive impairment.

Resting state of Electroencephalogram datathrough study completion, an average of 3 months

Electroencephalogram (EEG) data of the study were preprocessed and trends in functional brain network connectivity were analyzed.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sun Yat-sen Memorial Hospital of Sun Yat-sen University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath